Digitisation | December 17, 2025
Merck KGaA launches ChemiSphere App to digitize lab workflows
The ChemiSphere app exemplifies how M-Trust technology transforms workflows into seamless digital experiences
The ChemiSphere app exemplifies how M-Trust technology transforms workflows into seamless digital experiences
The upcoming trials will evaluate both active and chronic TED in randomized, double-blind, placebo-controlled studies
The randomized, double-blind, placebo-controlled single ascending dose (SAD) study evaluated safety, tolerability, pharmacokinetics, and target engagement in 46 healthy participants
Ryght AI tackles these hurdles with its AI Site Twin platform
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
Qfitlia is the first antithrombin (AT)-lowering therapy approved for routine prophylaxis in hemophilia
The drug is currently being evaluated in two fully recruited global Phase 3 studies for progressive and tophaceous gout, with results expected in 2026.
Clinical trial enrollment has long been a bottleneck in drug development
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
The inspection concluded with one minor observation in Form 483
Subscribe To Our Newsletter & Stay Updated
